Elavil and Tekturna drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Elavil (amitriptyline hydrochloride) and Tekturna (aliskiren hemifumarate). Common drug interactions include swollen tongue among females and cellulitis among males.
The phase IV clinical study analyzes what interactions people have when they take Elavil and Tekturna. It is created by eHealthMe based on reports of 12 people who take the same drugs from the FDA, and is updated regularly.
What is Elavil?
Elavil has active ingredients of amitriptyline hydrochloride. It is often used in depression. eHealthMe is studying from 20,724 Elavil users. Check the latest studies of Elavil.
What is Tekturna?
Tekturna has active ingredients of aliskiren hemifumarate. It is often used in high blood pressure. eHealthMe is studying from 4,730 Tekturna users. Check the latest studies of Tekturna.
12 people who take Elavil and Tekturna together, and have interactions are studied.

What are the common drug interactions of Elavil and Tekturna, by gender? *:
female:
- Swollen tongue (swelling of tongue)
- Adverse drug reaction
- Cough
- Drug effect decreased
- Glossodynia (a burning or painful sensation in the tongue)
- Muscle spasms (muscle contraction)
- Oedema (fluid collection in tissue)
- Pain
- Pharyngeal oedema (abnormal accumulation of fluid in the cavities and intercellular spaces of the pharyngeal)
- Tongue oedema (swelling of tongue)
male:
- Cellulitis (infection under the skin)
- Clostridium difficile colitis (inflammation of colon by clostridium difficile bacteria infection)
- Back pain
- Melaena (the passage of black, tarry stools)
- Myalgia (muscle pain)
- Renal failure (kidney dysfunction)
- Crohn's disease (a condition that causes inflammation of the gastrointestinal tract)
- Diarrhoea
- Drug ineffective
- Erythema (redness of the skin)
What are the common drug interactions of Elavil and Tekturna, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
n/a
50-59:
- Addison's disease (addison's disease, a hormonal disorder disease)
- Adrenal insufficiency (a condition in which the adrenal glands do not produce adequate amounts of steroids)
- Adverse drug reaction
- Application site erythema (redness of the skin at application site)
- Application site pain
- Application site rash
- Application site swelling
- Blood sodium decreased
- Candidiasis (candidiasis or thrush is a fungal infection)
- Dizziness
60+:
- Cough
- Cellulitis (infection under the skin)
- Pain in extremity
- Pollakiuria (abnormally frequent passage of relatively small quantities or urine)
- Pruritus generalised (generalized itching)
- Swollen tongue (swelling of tongue)
- Arthritis (form of joint disorder that involves inflammation of one or more joints)
- Back pain
- Epistaxis (bleed from the nose)
- Increased tendency to bruise (increased tendency to injure the underlying soft tissue or bone)
What are the existing conditions these people have? *
- Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 5 people, 41.67%
- Insomnia (sleeplessness): 4 people, 33.33%
- High Blood Cholesterol: 2 people, 16.67%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 16.67%
- Chest Pain: 2 people, 16.67%
- Clostridial Infection (infectious conditions by clostridium bacteria): 2 people, 16.67%
- Itching: 2 people, 16.67%
- Swelling: 2 people, 16.67%
- Diabetes: 2 people, 16.67%
- Allergic Sinusitis: 1 person, 8.33%
* Approximation only. Some reports may have incomplete information.
Do you take Elavil and Tekturna?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Elavil and Tekturna:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Elavil:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Tekturna:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Elavil and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Tekturna and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Li W, Lamichhane J, "From Heartbreak to Left Bundle Branch Block: A Case of Amitriptyline Overdose", American Journal of Therapeutics, 2017 Sep .
- Li W, Lamichhane J, "From Heartbreak to Left Bundle Branch Block: A Case of Amitriptyline Overdose", American Journal of Therapeutics, 2017 Sep .
How the study uses the data?
The study uses data from the FDA. It is based on amitriptyline hydrochloride and aliskiren hemifumarate (the active ingredients of Elavil and Tekturna, respectively), and Elavil and Tekturna (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Lyrica and Fluoxetine Hydrochloride drug interactions for women aged 60+ - 5 seconds ago
- Chills in Bupropion Hydrochloride, how severe and when it was recovered? - 7 seconds ago
- Could Hydroxychloroquine Sulfate cause Multiple Sclerosis Relapse? - 8 seconds ago
- Could Ramipril cause Dermatitis? - 11 seconds ago
- Cablivi and Nose Bleed for Women aged 30-39 - 19 seconds ago
- Cablivi and Nose Bleeds for Women aged 30-39 - 19 seconds ago
- Cablivi and Nosebleeds for Women aged 30-39 - 20 seconds ago
- Cablivi and Epistaxis for Women aged 30-39 - 20 seconds ago
- Cablivi and Bleeding From The Nose for Women aged 30-39 - 20 seconds ago
- Cablivi and Nosebleed for Women aged 30-39 - 21 seconds ago